Supplies of AstraZeneca's antibody drug for the treatment of Covid-19 are expected to arrive by the end of the year, after Singapore signed a new purchase agreement with the drugmaker.
Known as Evusheld, the drug cocktail is a combination of two "long" antibodies - which take longer to metabolise in the body and can provide longer-lasting protection for up to a year, compared with monoclonal antibodies.
A total of 298 new Covid-19 Variants of Concern (VOC) cases were reported between November 19 and December 8 this year, says Malaysian Health Ministry.
Its director-general Tan Sri Dr Noor Hisham Abdullah in the ministry’s daily Covid-19 update on Saturday (December 11) said the variants comprise Delta (B.1.617.2), Beta (B.1.1351), and one case of Omicron (B.1.1.529).